The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $55.16, representing a -2.56% change from its previous close.

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $62.56, representing a -2.51% change from its previous close.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Morningstar ( ($MORN) ) has shared an update. Morningstar, Inc. has addressed investor inquiries received up to September 30, 2025, focusing on ...

Vertex Pharmaceuticals Incorporated remains a leader in CF treatments, fueling robust cash flow and pipeline expansions.

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $67.21, marking a +1.04% move from the previous day.

Detailed price information for Value ETF Vanguard (VTV-A) from The Globe and Mail including charting and trades.

Vanguard launched VTV in early 2004, and it is a passive fund in the Large Value category. The ETF has an expense ratio of ...

The Vanguard Growth ETF takes a wider approach, tracking the CRSP US Large Cap Growth Index. Its portfolio also heavily tilts toward technology (62%), but with a slightly higher number of holdings ...

CRISPR Therapeutics (CRSP) recently showcased new preclinical results for its CTX460 therapy, revealing strong gene and mRNA correction in animal models for Alpha-1 Antitrypsin Deficiency. The ...